ReviewBreast (Edinburgh, Scotland)2022

Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer.

Matti Aapro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.